These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 39422907)

  • 1. Early Maternal Prenatal Cannabis Use and Child Developmental Delays.
    Avalos LA; Oberman N; Alexeeff SE; Croen LA; Davignon MN; Adams SR; Ansley D; Chambers CD; Steuerle K; Young-Wolff KC
    JAMA Netw Open; 2024 Oct; 7(10):e2440295. PubMed ID: 39422907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal Prenatal Cannabis Use and Child Autism Spectrum Disorder.
    Avalos LA; Shenkute M; Alexeeff SE; Oberman N; Croen LA; Davignon M; Adams SR; Ansley D; Castellanos C; Young-Wolff KC
    JAMA Netw Open; 2024 Oct; 7(10):e2440301. PubMed ID: 39422906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal Cannabis Use and Maternal Pregnancy Outcomes.
    Young-Wolff KC; Adams SR; Alexeeff SE; Zhu Y; Chojolan E; Slama NE; Does MB; Silver LD; Ansley D; Castellanos CL; Avalos LA
    JAMA Intern Med; 2024 Sep; 184(9):1083-1093. PubMed ID: 39037795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis Use During Early Pregnancy Following Recreational Cannabis Legalization.
    Young-Wolff KC; Slama NE; Avalos LA; Padon AA; Silver LD; Adams SR; Does MB; Ansley D; Castellanos C; Campbell CI; Alexeeff SE
    JAMA Health Forum; 2024 Nov; 5(11):e243656. PubMed ID: 39485336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal outcomes associated with in utero cannabis exposure: a population-based retrospective cohort study.
    Avalos LA; Adams SR; Alexeeff SE; Oberman NR; Does MB; Ansley D; Goler N; Padon AA; Silver LD; Young-Wolff KC
    Am J Obstet Gynecol; 2024 Jul; 231(1):132.e1-132.e13. PubMed ID: 38029850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Adverse Neonatal Outcomes After Combined Prenatal Cannabis and Nicotine Exposure.
    Crosland BA; Garg B; Bandoli GE; Mandelbaum AD; Hayer S; Ryan KS; Shorey-Kendrick LE; McEvoy CT; Spindel ER; Caughey AB; Lo JO
    JAMA Netw Open; 2024 May; 7(5):e2410151. PubMed ID: 38713462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of psychiatric and substance use disorders with cannabis use and cannabis use disorder during early pregnancy in northern California.
    Young-Wolff KC; Chi FW; Campbell CI; Does MB; Brown QL; Alexeeff SE; Ansley D; Wang X; Lapham GT
    Addiction; 2024 Nov; 119(11):1987-1997. PubMed ID: 39082097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-reported Daily, Weekly, and Monthly Cannabis Use Among Women Before and During Pregnancy.
    Young-Wolff KC; Sarovar V; Tucker LY; Conway A; Alexeeff S; Weisner C; Armstrong MA; Goler N
    JAMA Netw Open; 2019 Jul; 2(7):e196471. PubMed ID: 31322686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between maternal prenatal cannabis use and missed child preventive care visits in an integrated health care delivery system in Northern California.
    Avalos LA; Oberman N; Alexeeff SE; Croen LA; Adams SR; Davignon M; Young-Wolff KC
    Prev Med; 2023 Oct; 175():107716. PubMed ID: 37775081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geographic Accessibility of Retail Cannabis in Northern California and Prenatal Cannabis Use During the COVID-19 Pandemic.
    Young-Wolff KC; Slama NE; Padon AA; Silver LD; Soroosh A; Alexeeff SE; Adams SR; Does MB; Campbell CI; Ansley D; Conway A; Goler N; Avalos LA
    JAMA Netw Open; 2022 Nov; 5(11):e2244086. PubMed ID: 36445706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis Use During the Perinatal Period in a State With Legalized Recreational and Medical Marijuana: The Association Between Maternal Characteristics, Breastfeeding Patterns, and Neonatal Outcomes.
    Crume TL; Juhl AL; Brooks-Russell A; Hall KE; Wymore E; Borgelt LM
    J Pediatr; 2018 Jun; 197():90-96. PubMed ID: 29605394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal Cannabis Use and Offspring Attention Deficit Hyperactivity Disorder and Disruptive Behavior Disorders: A Retrospective Cohort Study.
    Young-Wolff KC; Kong K; Alexeeff SE; Croen LA; Oberman N; Kirane H; Ansley D; Davignon M; Adams SR; Avalos LA
    J Dev Behav Pediatr; 2024 Oct; ():. PubMed ID: 39400201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual and Combined Association Between Prenatal Polysubstance Exposure and Childhood Risk of Attention-Deficit/Hyperactivity Disorder.
    Garrison-Desany HM; Hong X; Maher BS; Beaty TH; Wang G; Pearson C; Liang L; Wang X; Ladd-Acosta C
    JAMA Netw Open; 2022 Mar; 5(3):e221957. PubMed ID: 35275164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Neurodevelopment in Infants With and Without Exposure to Asymptomatic or Mild Maternal SARS-CoV-2 Infection During Pregnancy.
    Firestein MR; Shuffrey LC; Hu Y; Kyle M; Hussain M; Bianco C; Hott V; Hyman SP; Kyler M; Rodriguez C; Tejeda Romero M; Tzul Lopez H; Alcántara C; Amso D; Austin J; Bain JM; Barbosa J; Battarbee AN; Bruno A; Ettinger S; Factor-Litvak P; Gilboa S; Goldman S; Gyamfi-Bannerman C; Maniatis P; Marsh R; Morrill T; Mourad M; Muhle R; Newes-Adeyi G; Noble KG; O'Reilly KC; Penn AA; Reichle L; Sania A; Semenova V; Silver WG; Smotrich G; Tita AT; Tottenham N; Varner M; Welch MG; Zork N; Garey D; Fifer WP; Stockwell MS; Monk C; Dawood F; Dumitriu D
    JAMA Netw Open; 2023 Apr; 6(4):e237396. PubMed ID: 37036706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in Cannabis Polysubstance Use During Early Pregnancy Among Patients in a Large Health Care System in Northern California.
    Young-Wolff KC; Sarovar V; Tucker LY; Ansley D; Goler N; Conway A; Ettenger A; Foti TR; Brown QL; Kurtzman ET; Adams SR; Alexeeff SE
    JAMA Netw Open; 2022 Jun; 5(6):e2215418. PubMed ID: 35666502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal Nicotine or Cannabis Exposure and Offspring Neurobehavioral Outcomes.
    Smid MC; Metz TD; McMillin GA; Mele L; Casey BM; Reddy UM; Wapner RJ; Thorp JM; Saade GR; Tita ATN; Miller ES; Rouse DJ; Sibai B; Costantine MM; Mercer BM; Caritis SN;
    Obstet Gynecol; 2022 Jan; 139(1):21-30. PubMed ID: 34856574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations Between Prenatal Cannabis Exposure and Childhood Outcomes: Results From the ABCD Study.
    Paul SE; Hatoum AS; Fine JD; Johnson EC; Hansen I; Karcher NR; Moreau AL; Bondy E; Qu Y; Carter EB; Rogers CE; Agrawal A; Barch DM; Bogdan R
    JAMA Psychiatry; 2021 Jan; 78(1):64-76. PubMed ID: 32965490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Gestational Weight Gain and Maternal Body Mass Index in Early Pregnancy With Risk for Nonaffective Psychosis in Offspring.
    Mackay E; Dalman C; Karlsson H; Gardner RM
    JAMA Psychiatry; 2017 Apr; 74(4):339-349. PubMed ID: 28241183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between prenatal and postnatal substance exposure and salivary C-reactive protein in early childhood.
    Simon SG; Eiden RD; Molnar DS; Huestis MA; Riis JL
    Neurotoxicol Teratol; 2023; 95():107134. PubMed ID: 36395973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal cannabis use in pregnancy and child neurodevelopmental outcomes.
    Corsi DJ; Donelle J; Sucha E; Hawken S; Hsu H; El-Chaâr D; Bisnaire L; Fell D; Wen SW; Walker M
    Nat Med; 2020 Oct; 26(10):1536-1540. PubMed ID: 32778828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.